Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
In Brief Objective: Although natural menopause is associated with loss of ovarian estrogen production, this life phase is followed by a significant increase in estrogen-related cancers, namely breast and endometrial cancer. These tissues, as well as adipose, skeletal, and vascular tissues and the brain are important sites of postmenopausal estrogen production. Circulating C19 steroid precursors are essential substrates for extragonadal estrogen synthesis; however, the levels of these androgenic precursors decline markedly with advancing age. This implies an increase in capacity for extragonadal tissues to produce estrogen with age. Design: To explore this, and the effects of the menopause transition and postmenopausal estrogen therapy on extragonadal estrogen biosynthesis, we have compared the expression of the aromatase gene and estrogen (ER) and androgen receptors (AR) in subcutaneous abdominal and gluteal fat taken from premenopausal (group 1: n = 11), postmenopausal (group 2: n = 10), and postmenopausal women taking estrogen therapy (group 3: n = 10). All subjects were of normal body mass index, euglycemic, and normolipemic. Results: The postmenopausal women were older (group 1, 43.1 ± 5.0 vs groups 2 and 3, 57.9 ± 7.4 years, P < 0.001 and 56.1 ± 4.5 years, P < 0.001, respectively) and had lower serum estradiol levels (group 2, 22.2 ± 3.2 vs group 1, 442.5 ± 248.2 pmol/L, P < 0.05), which were restored to premenopausal levels with estrogen therapy. Expression analysis revealed that levels of transcripts encoding aromatase were greater in gluteal than abdominal depots in each group in postmenopausal versus premenopausal women (P < 0.05). Use of hormone therapy did not influence aromatase gene expression in either depot. No differences were detected in the expression of ER or AR between groups of between tissue depots. Conclusion: Thus, the capacity of adipose tissue to produce estrogen seems to increase significantly with age at the time of menopause and to be unaltered by exogenous estrogen therapy. This difference in extragonadal estrogen production with age may play a pivotal role in the increase in estrogen-dependent malignancies in the postmenopausal years. To explore the effects of the menopause transition and exogenous estrogen on the capacity of adipose tissue to produce estrogen, this study compared the levels of expression of the aromatase gene and estrogen and androgen receptors in subcutaneous abdominal and gluteal fat from premenopausal women, postmenopausal women, and postmenopausal women using hormone therapy. Expression analysis revealed that capacity of adipose to synthesize estrogen appears to increase with age at the time of menopause and is unaltered by estrogen therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Labrie, F., Bélanger, A., Cusan, L., Gomez, J.-L., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4160 · Cited by 713 · cited 1×
“However, levels of the circulating C19 steroid precursors, which are essential substrates for this extragonadal estrogen synthesis, decline markedly with advancing age.(7) There is preliminary evidence that the expression of the aromatase enzyme, which is responsible for estrogen biosynthesis, increases in fat with ad…”
BackgroundHEMSELL, D. L., GRODIN, J. M., BRENNER, P. F., SIITERI, P. K., & MACDONALD, P. C. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-38-3-476 · Cited by 444
Labrie, F., Bélanger, A., Cusan, L., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4161 · Cited by 350
Bulun, S. E. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.2.428 · Cited by 188
Cited by
Estrogen synthesis and signaling pathways during aging: from periphery to brain
Cui, J., Shen, Y., & Li, R. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.12.007 · Cited by 779
Endogenous Hormones and Breast Cancer Collaborative Group (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.254 · Cited by 391
Androgen therapy in women: An Endocrine Society clinical practice guideline
Wierman, M. E., Basson, R., Davis, S. R., Khosla, S., Miller, K. K., Rosner, W., & Santoro, N. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1121 · Cited by 301
Self-citationTestosterone in women—the clinical significance
Davis, S. R., & Wahlin-Jacobsen, S. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00284-3 · Cited by 290
Self-citationTurgeon, J. L., Carr, M. C., Maki, P. M., Mendelsohn, M. E., & Wise, P. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0020 · Cited by 264
Metadata
- Authors
- Misso, M. L., Jang, C., Adams, J., Tran, J., Murata, Y., Bell, R., Boon, W. C., Simpson, E. R., & Davis, S. R.
- Venue
- Menopause
- Published
- 2005
- Volume
- 12
- Issue
- 2
- Pages
- 210-215
- ISSN
- 1072-3714 (ISSN-L)
- OpenAlex
- W1970201992
- Cited by
- 90
- References
- 4
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy. https://app.cochat.ai/papers/10.1097/00042192-200512020-00016
- The paper
- Misso, M. L., Jang, C., Adams, J., Tran, J., Murata, Y., Bell, R., Boon, W. C., Simpson, E. R., & Davis, S. R. (2005). Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy. Menopause. https://doi.org/10.1097/00042192-200512020-00016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.